Atorvastatin as a Rare Primary Cause of Drug-Induced Angioedema: A Case Report.
| Autor: | Voloshyna D; College of Medicine, University of Michigan, Ann Arbor, USA., Al Barznji S; Internal Medicine, University of Sulaymaniyah, Sulaymaniyah, IRQ., Shaik TA; Cardiovascular Medicine, University of Louisville School of Medicine, Louisville, USA., Rizvi A; General Practice, Swan Practice, Manchester, GBR., Sachdev R; Medicine, Ghulam Muhammad Mahar Medical College, Sukkur, PAK., Pritwani P; Internal Medicine, Ghulam Muhammad Mahar Medical College, Sukkur, PAK., Saleem F; Internal Medicine, Akhtar Saeed Medical and Dental College, Lahore, PAK., Ghaffari MAZ; Internal Medicine, Akhtar Saeed Medical and Dental College, Lahore, PAK. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2022 Sep 05; Vol. 14 (9), pp. e28788. Date of Electronic Publication: 2022 Sep 05 (Print Publication: 2022). |
| DOI: | 10.7759/cureus.28788 |
| Abstrakt: | In patients with hyperlipidemia and cardiovascular disease, statin remains the primary medication for risk reduction. Statins are primarily associated with adverse outcomes like myoglobinuria and deranged liver function tests (LFTs). Angioedema is a life-threatening reaction characterized by mucosal and submucosal swelling. It is rarely known for its association with statins. However, we present a rare case of a 59-year-old man presenting with recurrent angioedema of the face and tongue after starting on 40mg of atorvastatin, within one week of the treatment. He had no previous history of hypersensitivity and rash. He denied any food or medication allergy in the past. The Naranjo scale probability and the abrupt nature of these episodes upon starting statin and completely resolving after discontinuing the drug made statin-induced angioedema the primary diagnosis in this case. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2022, Voloshyna et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|